Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bet v 1 is the major allergen in birch pollen, belonging to the PR-10 protein family. It is a small protein with a hydrophobic cavity that binds ligands like flavonoids and iron. It plays a role in plant defense but is clinically relevant as the primary cause of birch pollen allergy, leading to allergic rhinitis and asthma. Sensitization is geographically variable, and cross-reactivity with other Fagales trees and certain foods is common. The allergenic potential is influenced by its ligand-binding state.
Immunotherapy (allergen-specific)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Birch pollen protein (Bet v 1).